Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges
Chunyan Duan, Mingjia Yu, Jiyuan Xu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114643-114643
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Nanomaterials in the Wound Healing Process: New Insights and Advancements
Tanikan Sangnim, Vivek Puri, Divya Dheer, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 300-300
Open Access | Times Cited: 23
2D Architectures-Transformed Conformational Nanoarchitectonics for Light-Augmented Nanocatalytic Chemodynamic and Photothermal/Photodynamic-Based Trimodal Therapies
Ruo-Yin Meng, Ying Zhao, Hong‐Ying Xia, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 4, pp. 1160-1177
Closed Access | Times Cited: 21
Biomimetic bone-periosteum scaffold for spatiotemporal regulated innervated bone regeneration and therapy of osteosarcoma
Yan Xu, Chao Xu, Huan Song, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Unleashing the power of polymeric nanoparticles — Creative triumph against antibiotic resistance: A review
Gaurisha Alias Resha Ramnath Naik, Amrita Arup Roy, Srinivas Mutalik, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134977-134977
Open Access | Times Cited: 13
Elesclomol-Copper Nanoparticles Overcome Multidrug Resistance in Cancer Cells
Qi Wang, Chung-Hui Huang, Fajar Setyo Wibowo, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 11, pp. 13509-13524
Closed Access | Times Cited: 9
Synthesis of Carbon Dots from Spent Coffee Grounds: Transforming Waste into Potential Biomedical Tools
Yingru Zhou, Adalberto Camisasca, Sofia Dominguez‐Gil, et al.
Nanoscale (2025)
Open Access | Times Cited: 1
Transition Metal Oxide‐Decorated MXenes as Drugless Nanoarchitectonics for Enriched Nanocatalytic Chemodynamic Treatment
Hong‐Ying Xia, Bo‐Yi Li, Ying‐Tong Ye, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 10
Closed Access | Times Cited: 22
Challenges and opportunities for improving the druggability of natural product: Why need drug delivery system?
Peng Tang, Tianze Shen, Hairong Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114955-114955
Open Access | Times Cited: 19
Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review
Adhithya Aravindan, Ashutosh Gupta, Sudheer Moorkoth, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106007-106007
Open Access | Times Cited: 8
Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment
Yuxuan Tu, Jianbao Gong, Jing Mou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Rhodamine 6G in Oxidized Sodium Alginate Polymeric Hydrogel for Photodynamically Inactivating Cancer Cells
Pragya Pallavi, Koyeli Girigoswami, Pemula Gowtham, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 35, pp. 2801-2812
Closed Access | Times Cited: 7
Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy
Ahmad Gholami, Milad Mohkam, Saeede Soleimanian, et al.
Microsystems & Nanoengineering (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Advances in the delivery of anticancer drugs by nanoparticles and chitosan-based nanoparticles
Prieložná Jarmila, Veronika Mikušová, Peter Mikuš
International Journal of Pharmaceutics X (2024) Vol. 8, pp. 100281-100281
Open Access | Times Cited: 7
Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives
Lanwen Gao, Fansu Meng, Zhenjiang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117327-117327
Open Access | Times Cited: 7
SIRT1-mediated deacetylation of FOXO3 enhances mitophagy and drives hormone resistance in endometrial cancer
Wei Xue-hua, Xiangpeng Xiong, Pingping Wang, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 6
Synergistic pH-responsive MUC-1 aptamer-conjugated Ag/MSN Janus nanoparticles for targeted chemotherapy, photothermal therapy, and gene therapy in breast cancer
Adel Mahmoudi Gharehbaba, Yadollah Omidi, Jaleh Barar, et al.
Biomaterials Advances (2024) Vol. 166, pp. 214081-214081
Closed Access | Times Cited: 6
Genetic Influence on Treatment Response in Psoriasis: New Insights into Personalized Medicine
Emilio Berná-Rico, Javier Perez-Bootello, Carlota Abbad‐Jaime de Aragón, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9850-9850
Open Access | Times Cited: 15
Applications of Curcumin and Its Nanoforms in the Treatment of Cancer
Deepa Mundekkad, William C. Cho
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2223-2223
Open Access | Times Cited: 15
Insights on the Role of Polyphenols in Combating Cancer Drug Resistance
Mohd Farhan
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1709-1709
Open Access | Times Cited: 12
Cancer Bioenergetics and Tumor Microenvironments—Enhancing Chemotherapeutics and Targeting Resistant Niches through Nanosystems
Aisha Farhana, Abdullah Alsrhani, Yusuf S. Khan, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3836-3836
Open Access | Times Cited: 12
Ataxia telangiectasia and Rad3-related (ATR) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response
Ainaz Mihanfar, Faezeh Asghari, Maryam Majidinia
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 4
Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer
Xiaojie Yan, Xueying Zhao, Mingde Fan, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3847-3859
Open Access | Times Cited: 4
Novel coumarin-6-sulfonamide-chalcone hybrids as glutathione transferase P1-1 inhibitors
Ahmed Sabt, Stefanos Kitsos, Manal S. Ebaid, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0306124-e0306124
Open Access | Times Cited: 4
Unraveling cancer progression pathways and phytochemical therapeutic strategies for its management
Vikas Sharma, Anis Ahmad Chaudhary, Sweta Bawari, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
NIR‐II AIEgens nanosystem for fluorescence and chemiluminescence synergistic imaging‐guided precise resection in osteosarcoma surgery
Ruotong Li, Kaiyuan Liu, Qian Hu, et al.
Aggregate (2024)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top